|Issuer:||VIRIDIAN THERAPEUTICS, INC.\DE (VRDN)|
|Original Submission Date:|
C/O VIRIDIAN THERAPEUTICS, INC.
221 CRESCENT STREET, SUITE 401 WALTHAM, MA 02453
|Title of Security||Transaction Date||2a. Deemed Execution Date||Transaction Code||Shares||Acquired or Disposed||Price per share||5. Amount of Securities Beneficially Owned Following Reported Transaction||6. Ownership Form Direct or Indirect||Nature of Indirect Ownership|
|Title of Derivative Security||Conversion or Exercise Price of Derivative Security||Transaction Date||Deemed Execution Date||Transaction Code||Number of Derivative Securities Acquired (A) or Disposed of (D)||Date Exercisable||Expiration Date||Title and Amount of Securities Underlying Derivative Security||Price of Derivative Security||Number of derivative Securities Beneficially Owned Following Reported Transaction(s)||Ownership Form: Direct (D) or Indirect (I)||Nature of Indirect Beneficial Ownership|
|f1||this transaction was executed pursuant to a rule 10b5-1 trading plan in multiple trades at prices ranging from $12.69 to $13.75. the price reported above reflects the weighted average sales price. the reporting person hereby undertakes to provide upon request to the sec staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.|